# teriparatide

NDC: 47781-652
Generic name: teriparatide
Labeler / Manufacturer: Alvogen, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20191114

FDA application: NDA211939

## Active ingredients

- TERIPARATIDE: 250 ug/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"47781-652"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=47781-652
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b007339-dd0d-f019-5e0a-9b1b0f75011c